FutureFuel’s Sales Recovery Meets a Cash Reality Check as FF Slides
FutureFuel’s stronger sales and narrower loss are encouraging, but cash outflow clouds the recovery. Its next-quarter forecast now needs proof.
Read the storyStocks
STORIES WITH TASTE
IHRT Falls About 54% in Snapshot as iHeartMedia Cuts Its Outlook
iHeartMedia sharply reduced its 2026 profit and cash-flow outlook. Radio advertising weakness and heavy debt help explain concerns behind the IHRT selloff.
MVST Falls About 64% in Snapshot as Revenue Slumps and Financing Risks Deepen
Microvast’s sharp snapshot decline follows weaker sales, shrinking margins and an unresolved going-concern warning. Debt refinancing is now a central risk.
MNDO Jumps About 44% in Snapshot as Enghouse’s $1.30 Cash Deal Sets the Focus
MIND CTI’s snapshot rally brings shares close to Enghouse’s proposed cash price. Approval, closing risk and the remaining merger spread now matter.
SMX Jumps About 108% in Snapshot as AI Materials Platform Plans Take Focus
SMX’s new AI materials announcement adds to its sharp rally. The project remains in development, while a recent reverse split complicates historical comparisons.
PEPG Jumps About 114% in Snapshot as New DM1 Trial Results Arrive
PepGen’s sharp snapshot gain accompanies new DM1 trial data. Small patient numbers, an active U.S. clinical hold and future funding remain important.
SMX and WCT Stand Out in After-Hours Snapshots as Reverse Splits Reset the Comparison
SMX and Wellchange appear with strong gains in the supplied Penny Gems snapshot, but November 9 reverse splits make comparable prices and share counts essential context.
NCPL Shows a 52.38% After-Hours Snapshot Gain as Nasdaq Extends Its Filing Deadline
Netcapital has until February 9 to file overdue reports. The snapshot rally brings attention, while missing financial statements and separate SEC allegations remain key context.
CODX Shows a 74.45% Gain in After-Hours Snapshot Ahead of Earnings
The latest supplied CODX snapshot shows $0.45 and a 74.45% gain. India tuberculosis plans, November 10 earnings and convertible financing frame the business story.
HRTX Jumps About 31% in Snapshot as CorMedix Asset Deal Reshapes Heron’s Future
Heron’s proposed asset sale brings cash and CorMedix shares, but closing conditions, debt and its next business strategy remain central for HRTX holders.
EDSA Jumps 34% on Kyorin Deal: $12 Million Upfront, Bigger Tests Ahead
EDSA's 34% snapshot rally follows a Kyorin licensing deal. Examine the $12 million upfront payment, conditional milestones, clinical evidence and chart risks.
High-Volume Penny Stocks: The Verified News Behind the November 9 Watchlist
INLF, NTCL and JDZG lead a supplied volume screen. Financing, hotel assets and corporate actions explain the context, but several catalysts remain unverified.